Influence of select extracellular matrix proteins on mesenchymal stem cell osteogenic commitment in three-dimensional contexts
Source abstract
Abstract
Growth factors have been shown to be powerful mediators of mesenchymal stem cell (MSC) osteogenic differentiation. However, their use in tissue engineered scaffolds not only can be costly but also can induce undesired responses in surrounding tissues. Thus, the ability to specifically promote MSC osteogenic differentiation in the absence of exogenous growth factors via the manipulation of scaffold material properties would be beneficial. The current work examines the influence of select extracellular matrix (ECM) proteins on MSC osteogenesis toward the goal of developing scaffolds with intrinsically osteoinductive properties. Fibrinogen (FG), fibronectin (FN) and laminin-1 (LN) were chosen for evaluation due to their known roles in bone morphogenesis or bone fracture healing. These proteins were conjugated into poly(ethylene glycol) diacrylate (PEGDA) hydrogels and their effects on encapsulated 10T½ MSCs were evaluated. Specifically, following 1week of culture, mid-term markers of various MSC lineages were examined in order to assess the strength and specificity of the observed osteogenic responses. PEG-LN gels demonstrated increased levels of the osteogenic transcription factor osterix relative to day 0 levels. In addition, PEG-FG and PEG-LN gels were associated with increased deposition of bone ECM protein osteocalcin relative to PEG-FN gels and day 0. Importantly, the osteogenic response associated with FG and LN appeared to be specific in that markers for chondrocytic, smooth muscle cell and adipocytic lineages were not similarly elevated relative to day 0 in these gels. To gain insight into the integrin dynamics underlying the observed differentiation results, initial integrin adhesion and temporal alterations in cell integrin profiles were evaluated. The associated results suggest that α(2), α(v) and α(6) integrin subunits may play key roles in integrin-mediated osteogenesis.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cellular Mechanics and Interactions · Mesenchymal stem cell research · Cell Adhesion Molecules Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (64)
Show source-provided references
1. Vitronectin and collagen I differentially regulate osteogenesis in mesenchymal stem cells10.1016/j.bbrc.2006.06.110 ↗
2. Extracellular matrix remodeling, integrin expression, and downstream signaling pathways influence the osteogenic differentiation of mesenchymal stem cells on poly(lactide-co-glycolide) substrates10.1089/ten.tea.2008.0055 ↗
3. Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells
4. Laminin-5 induces osteogenic gene expression in human mesenchymal stem cells through an ERK dependent pathway10.1091/mbc.e04-08-0695 ↗
5. Laminin-5 activates extracellular matrix production and osteogenic gene focusing in human mesenchymal stem cells10.1016/j.matbio.2006.10.001 ↗
6. ERK signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells on collagen I and vitronectin10.1080/15419060500242836 ↗
7. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells10.1359/jbmr.2002.17.1.101 ↗
8. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor10.1074/jbc.273.49.32988 ↗
9. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-510.1002/jcb.21074 ↗
10. Dissection of the osteogenic effects of laminin-332 utilizing specific LG domains: LG3 induces osteogenic differentiation, but not mineralization10.1016/j.yexcr.2007.12.007 ↗
11. Interactive effects of mechanical stretching and extracellular matrix proteins on initiating osteogenic differentiation of human mesenchymal stem cells10.1002/jcb.22356 ↗
12. Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells10.1016/j.yexcr.2006.09.013 ↗
13. Differentiation and cell surface expression of transforming growth factor-beta receptors are regulated by interaction with matrix collagen in murine osteoblastic cells10.1074/jbc.271.7.3938 ↗
14. Inhibition of ERK promotes collagen gel compaction and fibrillogenesis to amplify the osteogenesis of human mesenchymal stem cells in three-dimensional collagen I culture10.1089/scd.2008.0075 ↗
15. The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation10.1016/j.biomaterials.2006.08.033 ↗
16. Hwang NS, Varghese S, Li H, Elisseeff J. Regulation of osteogenic and chondrogenic differentiation of mesenchymal stem cells in PEG-ECM hydrogels. Cell Tissue Res 2011;344:499–509 [Epub 2011 Apr 19].10.1007/s00441-011-1153-2 ↗
17. Modulus-driven differentiation of marrow stromal cells in 3D scaffolds that is independent of myosin-based cytoskeletal tension10.1016/j.biomaterials.2010.11.065 ↗
18. Taking cell-matrix adhesions to the third dimension10.1126/science.1064829 ↗
19. Tissue architecture: the ultimate regulator of breast epithelial function10.1016/j.ceb.2003.10.016 ↗
20. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate10.1038/nmat2732 ↗
21. Appearance of fibronectin during the differentiation of cartilage, bone, and bone marrow10.1083/jcb.88.3.630 ↗
22. Immunofluorescent localization of type IV collagen and laminin during endochondral bone differentiation and regulation by pituitary growth hormone10.1016/0012-1606(80)90149-9 ↗
23. Assessment of bone formation during osteoneogenesis: a canine model10.1016/S0194-59989570252-0 ↗
24. Bueno · 2011
25. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells10.1038/nmat2269 ↗
26. Engineering the cell-material interface for controlling stem cell adhesion, migration, and differentiation10.1016/j.biomaterials.2011.02.004 ↗
27. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering10.1016/S0142-9612(02)00176-X ↗
28. The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells10.1016/j.biomaterials.2005.03.018 ↗
29. Protein adsorption to poly(ethylene oxide) surfaces10.1002/jbm.820251211 ↗
30. Integrin ligands at a glance10.1242/jcs.03098 ↗
31. Impact of endothelial cells and mechanical conditioning on smooth muscle cell extracellular matrix production and differentiation10.1089/ten.tea.2008.0179 ↗
32. Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage10.2144/000112401 ↗
33. Investigation of molecular transport and distributions in poly(ethylene glycol) hydrogels with confocal laser scanning microscopy10.1021/ma0475232 ↗
34. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation10.1529/biophysj.104.047746 ↗
35. Design and characterization of poly(ethylene glycol) photopolymerizable semi-interpenetrating networks for chondrogenesis of human mesenchymal stem cells10.1089/ten.2007.0075 ↗
36. Probing vocal fold fibroblast response to hyaluronan in 3D contexts10.1002/bit.22436 ↗
37. Uncoupled investigation of scaffold modulus and mesh size on smooth muscle cell behavior10.1002/jbm.a.32492 ↗
38. Nucleotypic effects without nuclei: genome size and erythrocyte size in mammals10.1139/g00-069 ↗
39. The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability10.1002/term.95 ↗
40. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities10.1016/j.biomaterials.2008.01.035 ↗
41. Influence of hydrogel material properties on vocal fold fibroblast extracellular matrix production and phenotype10.1016/j.actbio.2008.04.013 ↗
42. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage10.1002/jbm.a.10319 ↗
43. Manipulations in hydrogel chemistry control photoencapsulated chondrocyte behavior and their extracellular matrix production10.1002/jbm.a.20003 ↗
44. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells10.1016/j.biomaterials.2006.05.012 ↗
45. Influence of glycosaminoglycan identity on vocal fold fibroblast behavior10.1016/j.actbio.2011.06.034 ↗
46. The effects of intermittent dynamic loading on chondrogenic and osteogenic differentiation of human marrow stromal cells encapsulated in RGD-modified poly(ethylene glycol) hydrogels10.1016/j.actbio.2011.06.031 ↗
47. Synthetic hydrogel niches that promote hMSC viability10.1016/j.matbio.2005.03.004 ↗
48. Fibrin-filled scaffolds for bone-tissue engineering: an in vivo study10.1002/jbm.a.30147 ↗
49. Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering10.1016/j.biomaterials.2005.11.038 ↗
50. A novel poly(ethylene glycol)–fibrinogen hydrogel for tibial segmental defect repair in a rat model10.1002/jbm.a.30928 ↗
51. Induced osteogenesis—The biological principle and clinical applications10.1016/0022-4804(84)90218-X ↗
52. Fibrin sealant in orthopedic surgery10.1097/00003086-198802000-00033 ↗
53. Le Guehennec L, Layrolle P, Daculsi G. A review of bioceramics and fibrin sealant. Eur Cell Mater 2004;8:1–10.10.22203/eCM.v008a01 ↗
54. Fibrin glue as an osteoinductive protein in a mouse model10.1016/S0142-9612(02)00064-9 ↗
55. Addition of fibrin sealant to ceramic promotes bone repair: long-term study in rabbit femoral defect model10.1002/(SICI)1097-4636(199821)43:1<38::AID-JBM4>3.0.CO;2-N ↗
56. Fibrin-filled scaffolds for bone-tissue engineering: an in vivo study10.1002/jbm.a.30147 ↗
57. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation10.1016/S0142-9612(02)00618-X ↗
58. Cunin G, Boissonnet H, Petite H, Blanchat C, Guillemin G. Experimental vertebroplasty using osteoconductive granular material. Spine (Phila Pa) 1976;25:1070–6.10.1097/00007632-200005010-00006 ↗
59. Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels10.1016/j.biomaterials.2006.10.006 ↗
60. Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells10.1002/jbmr.278 ↗
61. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix10.1016/S8756-3282(00)00424-5 ↗
62. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity10.1002/jbm.a.30025 ↗
63. Effects of titanium surface roughness on mesenchymal stem cell commitment and differentiation signaling
64. Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation10.1002/jbm.a.30686 ↗